Horizons in Cancer Research. Volume 42. (Record no. 60127)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 07484nam a22004933i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3019211 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124115.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2011 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781617613784 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781617611117 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3019211 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3019211 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10663019 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)847931006 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC267 -- .H6742 2011eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.994 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Watanabe, Hiroto S. |
| 245 10 - TITLE STATEMENT | |
| Title | Horizons in Cancer Research. Volume 42. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2011. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (236 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Horizons in Cancer Research Series |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- HORIZONS IN CANCER RESEARCH. VOLUME 42 -- HORIZONS IN CANCER RESEARCH. VOLUME 42 -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Chapter I Signaling Pathways as Biomarkers in Human Renal Cell Carcinoma -- Summary -- Introduction -- Notch Signaling Pathway -- P53 Signaling Pathway -- HIF Signaling Pathway -- VEGF/R Signaling Pathway -- EGFR Signaling Pathway -- Carbonic Anhydrase 9 -- Fumarate Hydratase -- GLUT Transporters -- Crosstalk between Notch Pathway and HIF Signaling -- Crosstalk between Notch Pathway and EGFR Signaling -- Crosstalk between Notch Pathway and VEGF Signaling -- Crosstalk of Notch Pathway with P53 Signaling -- Conclusion -- Acknowledgments -- References -- Chapter II Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis and Prostate Tumor Growth -- Abstract -- Conclusion -- Acknowledgments -- References -- Chapter III Elapsed Times in the Management of Early Stage Breast Cancer -- Abstract -- Introduction -- Do longer elapsed times impact breast cancer outcomes? -- Detection to Treatment -- Detection to Diagnosis -- Detection to Surgery -- Surgery to Chemotherapy -- Surgery to Radiotherapy -- Summary & -- Caveats -- What are the predictors of longer elapsed times in Canada? -- Detection to Diagnosis -- Detection to Surgery -- Surgery to Chemotherapy -- Surgery to Radiotherapy -- Summary & -- Caveats -- A multi-interval multi-resolution analytics framework -- Conclusions -- Acknowledgments -- References -- Chapter IV Positional Cloning of Tumor Suppressor Genes from 3p21.3 Involved in Major Human Cancers -- 1. Abstract -- 2. Introduction -- 3. Results -- a) Localization of Critical Regions on the Short Arm of Chromosome 3 Using Allelotyping of the Dense Set of Polymorphic Markers. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Multiple interstitial deletions were found in prevalence to terminal deletions in 3p in five epithelial tumor types -- Chromosome 3p "hot spots" affected in major epithelial tumors -- Contribution of amplification events in allelic alterations of 3p microsatellites -- Correlation of 3p allelic alterations with tumor progression -- b) Careful Mapping of LUCA and AP20 Regions Using Real Time Quantitative PCR -- QPCR for detection copy number changes -- QPCR results for RCC, BC and SCLC tumor samples and cell lines -- Comparison of LOH and QPCR data. fine deletion mapping of homozygous deletions -- Complex 3p rearrangements in major epithelial cancers -- c) NotI-Microarrays to Identify Cancer Causing Genes and Develop Biomarkers for Early Diagnosis, Prognosis and Prediction of Major Types of Cancer -- d) Identification of Novel Tumor Suppressor Genes -- Conclusion -- Acknowledgments -- References -- Chapter V Novel Methylation-Dependent Markers/Tumor Suppressor Genes Involved in the Development of Renal Cell Cancer -- Abstract -- Introduction -- RCC Methylation Profiles of RASSF1A, SEMA3B, RARbeta2, RHOA, GPX1, USP4 Genes -- Genes in the LUCA Critical Region (3p21.31) -- Genes in a Novel 3p21.3 MECA3 Region (3р21.31) -- Genes from the Distal 3p Region (3p26-P22) -- RCC Specific Methylation Profile for Six 3p Genes -- Methylation Pattern of RASSF1A, RAR-Beta2, SEMA3B, GPX1 and Tumor Progression -- Expression Profiles of Cancer Associated Genes: RBSP3, SEMA3B, SEMA3F, NPRL2, HYAL1, HYAL2, ITGA9, VILL, CHL1, and ACY1 in RCC -- High Mutation Frequency of the Tumor Suppressors RASSF1 and RBSP3 (CTDSPL) in RCC -- NotI Microarrays for Identification of RCC Biomarkers -- Conclusion -- Acknowledgments -- References -- Chapter VI Human Papillomaviruses (HPVs), Genomic Instability and the DNA Damage Response -- Abstract -- Human Papillomaviruses and Cancer. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | The Role of HPV Oncoproteins in the Viral Life Cycle -- Disruption of G1/S-Cell Cycle Checkpoint Regulation by High-Risk HPV Oncoproteins -- The Role of High-Risk HPV Oncoproteins in Genomic Instability and Cancer -- The Cellular DNA Damage Response -- DNA Damage -- ATM and ATR DNA Damage Checkpoint Kinases -- Downstream Targets of ATM and ATR -- The Fanconi Anemia (FA) Pathway -- DNA Repair Mechanisms -- High-Risk HPV Oncoproteins and the DNA Damage Response -- High-Risk HPV Oncoproteins Stimulate DNA Damage -- High-Risk HPV E7 Expression Triggers a Host Cell DNA Damage Checkpoint Response -- Interactions between High-Risk HPV Oncoproteins and the DNA Damage Response Machinery -- How Does the High-Risk HPV E7 Oncoprotein Induce DNA Damage and DNA Damage Checkpoint Activation? -- Advantages and Disadvantages of Interference with the Host Cell DNA Damage Response by HPV Oncoproteins -- Exploitation of the DNA Damage Response and the Viral Life Cycle -- Abrogation of the DNA Damage Response -- Future Directions -- Acknowledgments -- References -- Chapter VII Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer -- Abstract -- Introduction -- Factors Associated with Brain Metastases -- 1. Chemotherapy -- 2. Stage -- 3. Histology and Age -- Treatment of Brain Metastases -- PCI in Patients with NSCLC (Table 2) -- 1. Nonrandomized Study of PCI -- 2. Randomized Stuies of PCI -- Toxicity of PCI -- PCI: When and How? -- Conclusion -- References -- Chapter VIII Importance of Cell Cycle Regulatory Proteins and Proliferation Markers in Conventional Renal Cell Carcinoma -- Abstract -- Introduction -- Methods -- Results -- Conclusion -- Introduction -- Materials and Methods -- Patient Groups -- Tissue Sampling and Immunohistochemistry -- Sample Scoring and Statistical Analysis -- Results -- Conclusion -- References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter IX Overview of Kidney Cancer: Symptoms, Diagnosis, and Treatments -- Signs and Symptoms -- Diagnosis -- Treatments -- References -- Index. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer -- Research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer -- Treatment. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Watanabe, Hiroto S. |
| Title | Horizons in Cancer Research. Volume 42 |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2011 |
| International Standard Book Number | 9781617611117 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Horizons in Cancer Research Series |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3019211">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3019211</a> |
| Public note | Click to View |
No items available.